Mandeville sophomore swimmer Avery Daigle didn’t really know what she was getting into at first. When USA Swimming reached ...

If there’s one thing a roving reporter always needs first thing in the morning, it’s a quick bite and a hot coffee.  Make ...

Eli Lilly has committed to setting a new standard for on-screen representation of common chronic diseases, and it walked the walk with its recent sponsorship of a segment on “Project Runway.” In the ...

Track your swims with our favorite best fitness trackers for swimming — all tested and reviewed by our experts. When you purchase through links on our site, we may earn an affiliate commission. Here’s ...

Of the title character in “Lost Evangeline,” it is said she “lived a great life of the imagination.” You could say the same about Evangeline’s creator, Kate DiCamillo. The beloved, Minneapolis-based ...

Eli Lilly has pulled the plug on a phase 2b obesity trial before enrolling a single patient, citing “strategic business reasons.” The study was designed to test bimagrumab, an asset Lilly acquired in ...

EVANGELINE PARISH — Construction crews have spent more than a year working nonstop—pouring concrete, raising steel beams, and bringing the new Evangeline Parish jail closer to reality. Now, officials ...

EVANGELINE PARISH, La (KLFY) — Evangeline Parish is set to open a new multimillion-dollar jail facility which will significantly expand its inmate capacity. The new jail, currently under construction, ...

Eli Lilly's shares have increased by about 10% over the past month. Clinical progress in the past few weeks has helped solidify its lead in the weight loss market. The company's prospects remain ...

Lilly King spent the last two days of her professional swimming career doing what she’s done so well for the last decade. On the penultimate day of the 2025 World Aquatics Championships in Singapore, ...

Eli Lilly, the maker of Zepbound and Mounjaro, said its experimental GLP-1 pill successfully helped adults with obesity lose weight in a Phase 3 trial, as the company moves closer to submitting the ...

Shares of Eli Lilly plummeted 14% on Thursday, pacing what would be the stock’s largest loss in decades after the pharmaceutical giant unveiled data for its obesity treatment pill that fell behind ...